Global Vibrating Mesh Nebulizer Market 2025 – 2034

Reports Description

According to Custom Market Insights (CMI), The size of the global Vibrating Mesh Nebulizer Market was worth around USD 1.2 billion in 2021 and is expected to reach USD 1.31 billion in 2022 and is predicted to grow to around USD 2.2 billion by 2030 with compound annual growth rate (CAGR) of roughly 17% between 2022 and 2030.

The report analyses the Vibrating Mesh Nebulizer market’s drivers and restraints and their impact on demand throughout the projection period. In addition, the report examines global opportunities in the Vibrating Mesh Nebulizer market.

Vibrating Mesh Nebulizer Market: Overview

Different kinds of vibrating mesh nebulizers are becoming more and more common among adult and pediatric patients as cutting-edge aerosol delivery equipment for respiratory therapy. Mesh nebulizers of many types have long been considered the cornerstone treatment for chronic lung illnesses, particularly asthma and chronic obstructive pulmonary disease (COPD). They are utilized in clinics, hospitals, and urgent care facilities. They dissolve pharmaceuticals into tiny aerosol droplets to deliver drugs directly to patients’ airways. Since piezoelectric material inside the nebulizer can produce droplets of various required sizes using several laser-drilled holes, vibrating mesh nebulizers have been a significant technological advancement in recent years.

Vibrating Mesh Nebulizer Market: COVID-19 Impact Analysis

An unprecedented global public health emergency, COVID-19, has influenced practically every industry, and its long-term repercussions are predicted to impact industry growth throughout the forecast period. Our ongoing study strengthens our research framework to ensure that the underlying COVID-19 problems and potential future directions are included. 

The paper provides information on COVID-19 while considering changes in consumer demand and behaviour, buying habits, supply chain rerouting, market forces today, and significant government initiatives. Then, considering the market impact of COVID-19, the updated report offers insights, analyses, projections, and forecasts.

Vibrating Mesh Nebulizer Market: Growth Drivers

Surging Prevalence of Chronic Respiratory Disorders to Fuel the Market Growth

Age is the most critical risk factor for any chronic respiratory illness. It has been noted that people, particularly in America, who are 65 years of age or older experience more significant lung problems such as asthma and COPD. In addition, it is anticipated that the market will rise in the years to come due to the recent increase in the prevalence of chronic respiratory disorders. However, some factors expected to impede market growth in the short term include the availability of various options for treating chronic diseases.

Availability Low-Power and High-Efficiency Nebulizers Offer Prospective Growth Opportunities to the Market Players

Medical device makers have attractive opportunities thanks to the patient population’s demand for low-power, high-efficiency nebulizers. Additionally, ongoing efforts to significantly improve the design of vibrating mesh nebulizers are anticipated to catalyze the rise. Attempts to lessen upper airway deposits are a recent example. Another positive aspect of piezoelectric-actuated vibrating mesh nebulizers in healthcare settings is their accessibility.

Vibrating Mesh Nebulizer Market: Segmentation Analysis

In our research scope, the Vibrating Mesh Nebulizer market is segmented into therapeutic type and end-user. The market is divided by therapeutic type into active and passive mesh nebulizers. Due to technical developments, portability, and greater efficiency of active mesh nebulizers compared to other nebulizers on the market, the dynamic mesh nebulizer segment is predicted to hold the highest share in the vibrator mesh nebulizer market by the end of 2021. It is also becoming well-known worldwide for its users based on the piezoelectric effect. By end-user, the market is estimated to be dominated by the hospitals& clinics segment throughout the studied period.

Report Scope

Key Insights:

• Per the analysis shared by our research analyst, the Vibrating Mesh Nebulizer market is estimated to grow annually at a CAGR of around 17% over the forecast period (2025-2034).
• Regarding revenue, the vibrating Mesh Nebulizer market size was valued at around USD 1.2 billion in 2021 and is projected to reach USD 2.2 billion by 2030. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
• Based on therapeutic type, the active mesh nebulizer segment was estimated to hold the maximum market share in 2021.
• By end-user, the hospitals & clinics segment was estimated to hold the maximum market share in 2021.
• Based on geography/region, the North American part was the leading revenue generator in 2021.

Recent Development

• December2021:Following months of joint development, CanSinoBIO and Aerogenhave announced a partnership for the development and commercial supply of ConvideciaTM, a recombinant novel coronavirus vaccine from CanSinoBIO that will be administered via inhalation using Aerogen’s patented vibrating mesh aerosol drug delivery technology.
• December 2021: AerogenPharma, a provider of cutting-edge inhaled therapies for patients in critical care, and Nuance Pharma (“Nuance”), a specialty care-focused biopharma with ongoing commercial operations and late-stage clinical programs, today announced an exclusive collaboration in Greater China to create a superior, non-invasive method of treating RDS, a condition that poses a severe threat to the lives of preterm infants and is linked to long-term lung health problems in survivors.

Regional Landscape

Due to the widespread use of nebulizer devices, rising rates of asthma and COPD among the obese population, and increasing demand for high-quality healthcare items, North America now holds a dominant position in the vibrating mesh nebulizer market. Due to the increased prevalence of chronic respiratory disorders, the ease of product availability, and the widespread use of nebulizers, Europe has the highest predicted growth in the vibrating mesh nebulizer market.

The country part of the vibrating mesh nebulizer market research also lists specific market-affecting factors and domestic market regulation changes that impact the market’s present and future trends. Data points, including consumption patterns, manufacturing locations, output, import-export analysis, price trend analysis, raw material costs, and downstream and upstream value chain analysis, are critical indicators used to forecast certain nations’ market environments. In addition, when offering prediction analysis of the country data, the presence and accessibility of international brands, the difficulties they face due to intense or minimal competition from local and domestic brands, the influence of domestic tariffs, and trade routes are also considered.

Competitive Landscape

Due to the presence of significant companies, the nebulizer market is mature. However, developing highly advanced mesh nebulizers has opened up numerous prospects for businesses like Vectura Group and PARI Pharma. Mesh nebulizers are another device used widely by pharmaceutical corporations in drug research. For instance, mesh nebulizers rather than jet nebulizers are more frequently used in clinical trials sponsored by pharmaceutical companies, according to an analysis of clinical trial databases from the United States and Europe.

Companies are using new product creation, acquisitions, and collaborations with other players or research institutes to set their products apart from the other market participants.

List of the prominent players in the global Vibrating Mesh Nebulizer market:

• PARI GmbH
• Jiangsu Yuyue Medical Instruments Co. Ltd.
• Aerogen
• OMRON Corporation
• Koninklijke Philips N.V.
• Health & Life Co., Ltd.
• Vectura Group Plc
• HCmed Innovations Co. Ltd.
• Philips Healthcare

The global Vibrating Mesh Nebulizer market is segmented as follows:

By Therapeutic Type

• Active mesh nebulizers
• Passive mesh nebulizers

By End-user

• Hospitals & Clinics
• Emergency Centers
• Home Use

By Application 

• COPD
• Asthma
• Cystic Fibrosis
• Others

BY Age Group 

• Adults
• Paediatrics

On the basis of Geography

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America